Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ideaya Biosciences
Biotech
Sarepta CEO to step down as DM1 hits home—Chutes & Ladders
Sarepta CEO to step down as DM1 hits close to home. Pops descends from Alkermes CEO seat. Former Novartis CMO Tsai saunters to Daiichi.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
Feb 27, 2026 8:30am
GSK initiates breakup with Ideaya, hands back 2 programs
Dec 9, 2025 7:15am
Servier hands Ideaya $210M upfront for ex-US rights to PKC asset
Sep 2, 2025 3:02pm
Amgen and Ideaya ax cancer combination trial
Feb 13, 2025 7:34am
BeiGene, Brii and Ideaya ring in 2025 with deals
Jan 2, 2025 8:30am
Ideaya pushes ahead with Biocytogen bispecific ADC bet
Nov 11, 2024 8:50am